Merck Announces $1 Billion Investment to Expand Vaccine Production Facility
Introduction:
Merck has inaugurated a cutting-edge vaccine manufacturing facility at its Durham, North Carolina site. This $1 billion, 225,000-square-foot expansion is part of the company’s broader initiative to enhance domestic production and research capabilities.
Features:
The newly established facility integrates advanced manufacturing technologies, drawing from best practices across Merck’s global network.
It incorporates data analytics, generative AI, and 3D printing to optimize production.
A state-of-the-art training center, featuring a digital twin—a virtual simulation of the manufacturing floor—enhances employee training and process development.
These advancements underscore Merck’s commitment to innovation, efficiency, and workforce empowerment in the biopharmaceutical industry.
The new facility is planned to open by 2028.
Specifications:
| Name : | Merck |
| Type : | Expansion |
| Budget : | $1 Billion |
| Year : | 2028 |
